Douglas Flora: Turning AI into a world-class medical detective
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post on LinkedIn:
“Turning AI into a world-class medical detective!
Imagine asking an oncologist to sift through mountains of scattered, handwritten lab reports to find a single test result that could change a patient’s treatment. Now, imagine doing that across millions of patients, in seconds, with the accuracy of an expert. That’s the breakthrough AI is delivering.
In this must-read study, Aaron Cohen, Blythe Adamson, Jonathan Larch, and Guy Amster, alongside Flatiron Health, demonstrate how fine-tuned large language models (LLMs) can extract PD-L1 biomarker details from electronic health records with unprecedented accuracy and efficiency.
Unlike traditional deep learning models, these AI systems can adapt to the complexity of real-world medical documentation, transforming unstructured data into immediately useful insights for oncologists and researchers.
We are especially proud to highlight the work of Blythe Adamson, one of our esteemed AIPO editors, whose contributions continue to shape the future of AI in oncology. This research has real-world impact—from improving precision medicine to accelerating clinical trial enrollment.
As AI revolutionizes cancer care, this study is a must-read in our upcoming issue of AI in Precision Oncology!”
Large Language Model Extraction of PD-L1 Biomarker Testing Details From Electronic Health Records.
Authors: Aaron B. Cohen, et al.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023